Infant mortality and under five mortality rates in Ethiopia are among the highest in the world. D... more Infant mortality and under five mortality rates in Ethiopia are among the highest in the world. Diarrhoeal diseases, vaccine preventable diseases (VPDs) and malnutrition are responsible for a majority of childhood deaths in Ethiopia. The Expanded Program on Immunisation (EPI) started in Ethiopia in 1980 with the intention of increasing the immunisation coverage by 10% annually and reach 100% coverage in 1990. At this point, the immunisation coverage figures vary largely between regions, from more than 80% DPT 3 coverage in Tigray to less than 5% in Somali and Afar regions, resulting in a national DPT 3 coverage of about 50% (DPT 3 = 3 doses of diptheria, pertussis and tetanus). The long-term goal of the Ministry of Health EPI Strategy is to achieve 90% DPT 3 coverage in all regions. Ethiopia is a very diverse country, with a need for development of specific strategies for reaching each area. By the implementation of new approaches called Reaching Every District (RED) and Sustainable Out-reach Services (SOS), the present target is to increase the coverage in certain priority areas by 10% and in others by 5%, giving a total national immunisation increase of 6% in a year. The objective set in 1980 was not met because of factors such as poor health infrastructure, low number of trained manpower, high turn over of staff and lack of donor funding. The same factors still affect the program today. The EPI program is run by the Ministry of Health (MoH) in close cooperation with WHO, UNICEF and other partners and implemented in each region by the Regional Health Bureaus. WHO provides technical assistance to the Ministry of Health and assists in planning, resource mobilisation and social mobilisation.
If you wish to comment on this version of the guideline, please be aware that all the supporting ... more If you wish to comment on this version of the guideline, please be aware that all the supporting information and evidence is contained in the full version. This is the consultation draft of a partial update of NICE clinical guideline 6 (www.nice.org.uk/CG006). New or amended recommendations are indicated by a green bar in the right-hand side of the page, flagged [NEW]. Key recommendations have been selected from the new or amended recommendations. Please comment on new or amended recommendations only. Recommendations that are unchanged from the original guideline are not being consulted on. A separate consultation will take place on the proposed assessment tool (see Section 14 of the full guideline) between 9 October and 3 December 2007. At this point, further information will be made available on the NICE website.
If you wish to comment on this version of the guideline, please be aware that all the supporting ... more If you wish to comment on this version of the guideline, please be aware that all the supporting information and evidence is contained in the full version. This is the consultation draft of a partial update of NICE clinical guideline 6 (www.nice.org.uk/CG006). New or amended recommendations are indicated by a green bar in the right-hand side of the page, flagged [NEW]. Key recommendations have been selected from the new or amended recommendations. Please comment on new or amended recommendations only. Recommendations that are unchanged from the original guideline are not being consulted on. A separate consultation will take place on the proposed assessment tool (see Section 14 of the full guideline) between 9 October and 3 December 2007. At this point, further information will be made available on the NICE website.
Infant mortality and under five mortality rates in Ethiopia are among the highest in the world. D... more Infant mortality and under five mortality rates in Ethiopia are among the highest in the world. Diarrhoeal diseases, vaccine preventable diseases (VPDs) and malnutrition are responsible for a majority of childhood deaths in Ethiopia. The Expanded Program on Immunisation (EPI) started in Ethiopia in 1980 with the intention of increasing the immunisation coverage by 10% annually and reach 100% coverage in 1990. At this point, the immunisation coverage figures vary largely between regions, from more than 80% DPT 3 coverage in Tigray to less than 5% in Somali and Afar regions, resulting in a national DPT 3 coverage of about 50% (DPT 3 = 3 doses of diptheria, pertussis and tetanus). The long-term goal of the Ministry of Health EPI Strategy is to achieve 90% DPT 3 coverage in all regions. Ethiopia is a very diverse country, with a need for development of specific strategies for reaching each area. By the implementation of new approaches called Reaching Every District (RED) and Sustainable Out-reach Services (SOS), the present target is to increase the coverage in certain priority areas by 10% and in others by 5%, giving a total national immunisation increase of 6% in a year. The objective set in 1980 was not met because of factors such as poor health infrastructure, low number of trained manpower, high turn over of staff and lack of donor funding. The same factors still affect the program today. The EPI program is run by the Ministry of Health (MoH) in close cooperation with WHO, UNICEF and other partners and implemented in each region by the Regional Health Bureaus. WHO provides technical assistance to the Ministry of Health and assists in planning, resource mobilisation and social mobilisation.
If you wish to comment on this version of the guideline, please be aware that all the supporting ... more If you wish to comment on this version of the guideline, please be aware that all the supporting information and evidence is contained in the full version. This is the consultation draft of a partial update of NICE clinical guideline 6 (www.nice.org.uk/CG006). New or amended recommendations are indicated by a green bar in the right-hand side of the page, flagged [NEW]. Key recommendations have been selected from the new or amended recommendations. Please comment on new or amended recommendations only. Recommendations that are unchanged from the original guideline are not being consulted on. A separate consultation will take place on the proposed assessment tool (see Section 14 of the full guideline) between 9 October and 3 December 2007. At this point, further information will be made available on the NICE website.
If you wish to comment on this version of the guideline, please be aware that all the supporting ... more If you wish to comment on this version of the guideline, please be aware that all the supporting information and evidence is contained in the full version. This is the consultation draft of a partial update of NICE clinical guideline 6 (www.nice.org.uk/CG006). New or amended recommendations are indicated by a green bar in the right-hand side of the page, flagged [NEW]. Key recommendations have been selected from the new or amended recommendations. Please comment on new or amended recommendations only. Recommendations that are unchanged from the original guideline are not being consulted on. A separate consultation will take place on the proposed assessment tool (see Section 14 of the full guideline) between 9 October and 3 December 2007. At this point, further information will be made available on the NICE website.
Uploads